Nasdaq began listing the Canary Staked INJ ETF under ticker INJC on November 5, 2026, according to its listing notice and Canary Capital. Canary says the fund seeks exposure to Injective’s INJ token and staking rewards, with net rewards reflected in the fund’s net asset value.
Owning fund shares is not the same as directly holding or controlling INJ. Fund expenses, staking arrangements, validator performance and timing can affect the value shareholders receive. The listing does not establish investor demand, liquidity in all market conditions or how closely shares will trade to net asset value.
